Treatment of unresponsive hypoparathyroidism when the oral route administration is not possible: considering subcutaneous teriparatide

Endocrinol Nutr. 2015 Aug-Sep;62(7):361-2. doi: 10.1016/j.endonu.2015.03.006. Epub 2015 May 8.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Arthralgia / chemically induced
  • Calcitriol / administration & dosage
  • Calcitriol / therapeutic use
  • Calcium / administration & dosage
  • Calcium / therapeutic use
  • Carcinoma, Squamous Cell / surgery
  • Drug Resistance
  • Hormone Replacement Therapy / methods*
  • Humans
  • Hypocalcemia / drug therapy
  • Hypocalcemia / etiology
  • Hypoparathyroidism / drug therapy*
  • Hypoparathyroidism / etiology
  • Injections, Subcutaneous
  • Intubation, Gastrointestinal
  • Laryngeal Neoplasms / surgery
  • Laryngectomy
  • Male
  • Middle Aged
  • Off-Label Use
  • Parathyroidectomy / adverse effects
  • Postoperative Complications / drug therapy*
  • Postoperative Complications / etiology
  • Teriparatide / administration & dosage*
  • Teriparatide / adverse effects
  • Teriparatide / therapeutic use
  • Thyroidectomy
  • Thyroxine / administration & dosage
  • Thyroxine / therapeutic use

Substances

  • Teriparatide
  • Calcitriol
  • Thyroxine
  • Calcium